Tecnologia sanitaria
Società Argentina impegnate nel settore: tecnologia sanitaria
Queste Società Argentina operano nello stesso settore, tecnologia sanitaria. Vengono fornite quotazioni, variazioni e altre statistiche per aiutarti a ottenere il massimo livello di dettaglio. L'elenco contiene titoli adatti a qualsiasi strategia: giganti a grande capitalizzazione come le ELI LILLY AND COMPANY CEDEAR EACH 56 REP 1 (USD), top gainer come le INTUITIVE SURGICAL INC CEDEAR EACH 90 REP 1 ORD e altri ancora. Filtra l'elenco e controlla le performance delle aziende in modo pratico.
Simbolo | Cap mercato | Prezzo | Variazione % | Volume | Volume rel | P/E | EPS dil TTM | EPS diluito crescita TTM YoY | Rendimento div % TTM | Rating analisti |
|---|---|---|---|---|---|---|---|---|---|---|
 LLYDELI LILLY AND COMPANY CEDEAR EACH 56 REP 1 (USD)DR | 749,17 T ARS | 13,600 USD | −3,55% | 381 | 0,88 | 105,55 | 124,85 ARS | +178,70% | 0,33% | — |
| LLYELI LILLY AND COMPANY CEDEAR EACH 56 REP 1 DR | 749,17 T ARS | 15.525,000 ARS | −4,17% | 11,06 K | 1,77 | 124,34 | 124,85 ARS | +564,33% | 0,33% | — |
 JNJDJOHNSON & JOHNSON CEDEAR EACH 15 REP 1 ORD SHS(USD)DR | 370,6 T ARS | 10,000 USD | −0,99% | 1,49 K | 1,00 | 31,57 | 306,92 ARS | +50,08% | 1,67% | — |
| DJNJ3JOHNSON & JOHNSON CEDEAR(REPR 6.95% BDS) DR | 370,6 T ARS | 1.250,000 ARS | 0,00% | 5 | 0,31 | — | — | — | — | — |
| JNJJOHNSON & JOHNSON CEDEAR EACH 15 REP 1 ORD SHS DR | 370,6 T ARS | 11.625,000 ARS | −0,64% | 12,87 K | 0,15 | 37,88 | 306,92 ARS | +257,75% | 1,67% | — |
 ABBVDABBVIE INC CEDEAR EA 10 REP 1 COM(USD)DR | 319,74 T ARS | 17,950 USD | +0,84% | 2 | 0,03 | 7,42 | 2.343,37 ARS | +18,73% | 1,70% | — |
| ABBVABBVIE INC CEDEAR EACH 10 REPR 1 COM DR | 319,74 T ARS | 20.450,000 ARS | −0,85% | 1,9 K | 1,33 | 8,73 | 2.343,37 ARS | +183,01% | 1,70% | — |
 MRKDMERCK & CO INC CEDEAR EAC 5 RE 1 (USD)DR | 265,35 T ARS | 20,400 USD | −3,77% | 5 | 0,10 | 22,38 | 883,37 ARS | +319,19% | 1,56% | — |
| MRKMERCK & CO INC CEDEAR (5 REP 1 USD0.50) DR | 265,35 T ARS | 23.325,000 ARS | −2,51% | 1,45 K | 0,76 | 26,40 | 883,37 ARS | +899,22% | 1,56% | — |
 TMOTHERMO FISHER SCIENTIFIC INC CEDEAR EACH 22 REP 1DR | 223,81 T ARS | 30.200,000 ARS | −0,25% | 271 | 0,75 | 54,03 | 558,94 ARS | +251,94% | 0,16% | — |
 ISRGINTUITIVE SURGICAL INC CEDEAR EACH 90 REP 1 ORDDR | 216,71 T ARS | 8.090,000 ARS | +13,94% | 258 | 3,48 | 152,96 | 52,89 ARS | +386,62% | 0,00% | — |
 AZNDASTRAZENECA PLC CEDEAR EA RE 0.5 ADR (USD)DR | 214,29 T ARS | 34,400 USD | +2,69% | 2 | 0,07 | 49,18 | 677,80 ARS | +64,44% | 1,44% | — |
| AZNASTRAZENECA PLC CEDEAR EACH REP 0.5 ADR USD0.25 DR | 214,29 T ARS | 39.675,000 ARS | −0,44% | 214 | 0,17 | 58,53 | 677,80 ARS | +291,99% | 1,44% | — |
 ABTDABBOTT LABORATORIES CEDEAR EAC 4 REP 1(USD)DR | 205,8 T ARS | 28,450 USD | −3,23% | 19 | 0,68 | 43,76 | 629,98 ARS | +55,55% | 0,92% | — |
| ABTABBOTT LABORATORIES CEDEAR EACH 4 REP 1 DR | 205,8 T ARS | 33.825,000 ARS | +0,30% | 706 | 0,37 | 53,69 | 629,98 ARS | +270,79% | 0,92% | — |
 NVSDNOVARTIS AG CEDEAR EAC 4 REP 1(USD)DR | 205,07 T ARS | 25,300 USD | −0,39% | 1 | 0,31 | 2,83 | 8.672,72 ARS | +140,89% | 3,64% | — |
| NVSNOVARTIS AG CEDEAR EACH 4 REP 1 DR | 205,07 T ARS | 29.025,000 ARS | −2,19% | 116 | 0,54 | 3,35 | 8.672,72 ARS | +474,20% | 3,64% | — |
 DHRDANAHER CORP CEDEAR EACH 54 REP 1 ORDDR | 182 T ARS | 5.290,000 ARS | +0,57% | 417 | 1,19 | 71,72 | 73,76 ARS | +137,74% | 0,19% | — |
 PFEDPFIZER INC CEDEAR 4 REP 1 ORD USD0.05(USD)DR | 156,37 T ARS | 6,730 USD | −0,59% | 3,99 K | 2,13 | 27,78 | 234,71 ARS | +35,96% | 3,15% | — |
| PFEPFIZER INC CEDEAR EACH 4 REP 1 ORD USD0.05 DR | 156,37 T ARS | 7.830,000 ARS | −0,13% | 14,07 K | 0,49 | 33,36 | 234,71 ARS | +224,10% | 3,15% | — |
 AMGNDAMGEN INC CEDEAR EACH 30REPR 1 ORD USD0.0001 (USD)DR | 150,86 T ARS | 9,750 USD | −2,30% | 54 | 0,89 | 37,93 | 249,09 ARS | −50,42% | 2,29% | — |
| AMGNAMGEN INC CEDEAR EACH 30 REP 1 DR | 150,86 T ARS | 10.800,000 ARS | +1,17% | 4,41 K | 1,06 | 43,36 | 249,09 ARS | +18,17% | 2,29% | — |
 BMYDBRISTOL-MYERS SQUIBB CO CEDEAR EACH 3 REP 1 USDDR | 119,11 T ARS | 19,100 USD | +1,06% | 5 | 0,61 | — | −1.078,84 ARS | −253,68% | 2,07% | — |
| BMYBRISTOL-MYERS SQUIBB CO CEDEAR EACH 3 REP 1 DR | 119,11 T ARS | 22.325,000 ARS | +0,11% | 1,83 K | 4,24 | — | −1.078,84 ARS | −466,33% | 2,07% | — |
 GILDDGILEAD SCIENCES INC CEDEAR EACH 4 REP 1 SHS (USD)DR | 118,98 T ARS | 25,100 USD | +2,03% | 7 | 0,65 | — | −50,65 ARS | −107,71% | 1,68% | — |
| GILDGILEAD SCIENCES INC CEDEAR EACH 4 REP 1 COM USD0.001 DR | 118,98 T ARS | 27.500,000 ARS | +1,48% | 2,63 K | 5,99 | — | −50,65 ARS | −118,38% | 1,68% | — |
 MDTMEDTRONIC PLC CEDEAR EACH 4 REP 1DR | 116,42 T ARS | 26.300,000 ARS | +1,94% | 1,05 K | 0,69 | 39,11 | 672,48 ARS | +274,72% | 1,91% | — |
 GSKDGSK PLC CEDEAR EACH REPR 1/4 ADR (USD)DR | 70,13 T ARS | 8,150 USD | −4,12% | 93 | 1,58 | 25,65 | 307,84 ARS | −37,30% | 3,17% | — |
| GSKGSK PLC CEDEAR EACH REPR 1/4 ADR DR | 70,13 T ARS | 9.930,000 ARS | −0,30% | 505 | 0,74 | 32,26 | 307,84 ARS | +49,45% | 3,17% | — |
 PHGKONINKLIJKE PHILIPS NV CEDEAR EACH REPR 1/5 ADRDR | 24,94 T ARS | 6.150,000 ARS | 0,00% | 14,41 K | 81,59 | — | −689,04 ARS | −3,81% | 0,00% | — |
 BIIBDBIOGEN INC CEDEAR EAC 13 RE 1 COM(USD)DR | 21,44 T ARS | 11,600 USD | −1,28% | 9 | 0,55 | 16,16 | 695,64 ARS | +96,62% | 0,00% | — |
| BIIBBIOGEN INC CEDEAR EACH 13 REP 1 COM USD0.0005 DR | 21,44 T ARS | 12.850,000 ARS | −1,15% | 469 | 0,75 | 18,47 | 695,64 ARS | +368,68% | 0,00% | — |
 MRNADMODERNA INC CEDEAR EACH 19 REP 1 ORD (USD)DR | 13,53 T ARS | 1,900 USD | −5,00% | 300 | 1,75 | — | −262,17 ARS | +31,39% | 0,00% | — |
| MRNAMODERNA INC CEDEAR EACH 19 REP 1 ORD DR | 13,53 T ARS | 2.125,000 ARS | 0,00% | 64,91 K | 1,26 | — | −262,17 ARS | −63,54% | 0,00% | — |
 RICHLABORATORIOS RICHMOND SACIF | 137,28 B ARS | 1.715,000 ARS | +0,88% | 9,41 K | 0,58 | 17,81 | 96,29 ARS | — | 0,00% | — |
 ROSEINSTITUTO ROSENBUCH SA DE BIOLOGIA | 4,6 B ARS | 108,000 ARS | 0,00% | 3,95 K | 0,77 | 25,30 | 4,27 ARS | +64,50% | 0,00% | — |